AGEPHA Pharma launches MACUSAN A2: A dietary supplement developed with essential nutrients to reduce progression of Age-Related Macular Degeneration (AMD)
)
AGEPHA Pharma is excited to announce the launch of MACUSAN A2, a new dietary supplement designed to meet the unique nutritional needs of patients with Age-Related Macular Degeneration (AMD).
Key Features of MACUSAN A2:
- Clinically proven formulation: Based on the renowned AREDS2 study, ensuring efficacy and safety.
- Essential nutrients: Includes Lutein, Zeaxanthin, Zinc oxide, Copper oxide, Vitamin E, and Vitamin C, which are vital for maintaining eye health.
- Convenient daily dosage: Two capsules per day
- Competitive pricing: Offers an affordable solution for patients seeking to manage AMD.
- Recommended by Eye Health Professionals: Trusted and recommended by experts in the field.
For more information, please visit www.macusan.com or contact maelis.robin@agephapharma.com
About Agepha Pharma
AGEPHA Pharma is a European pharmaceutical company specialised in multiple therapeutic areas, with a primary focus on ophthalmology.
Known for the reintroduction of aciclovir 3% eye ointment in the United Kingdom, AGEPHA Pharma offers a comprehensive range of ophthalmic products, including prescription medications and over-the-counter products.
Contact:
Maelis Robin
Marketing Manager
maelis.robin@agephapharma.com
www.macusan.com
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
){kind=logo}
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
.png/fit-in/500x500/filters:no_upscale())
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
){kind=logo}
)
)
)
){kind=logo}
)
){kind=logo}
)
){kind=logo}
)
)
)
)
)
)
)
)
)
){kind=logo}
)
)
.png/fit-in/1280x9999/filters:no_upscale()){kind=logo}
)
)
)
){kind=logo}
)
